Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad cholesterol. The new class of PCSK-9 inhibitors is being approved by the FDA which works by helping the liver flush out the bad cholesterol instead of preventing the body from making low-density lipoproteins. The FDA has till now approved only two drugs Praluent and Repatha, both made from living things. The PCSK-9 is a protein which binds to the receptors, those which are responsible for getting the bad cholesterol out of the body.
The cholesterol lowering biologics drug market is expected to boom owing to the number of population with high cholesterol levels, sedentary lifestyle and increasing research developments. According to the Indian Council of Medical Research, at least three-fourth of the country’s population has dyslipidemia, a condition where the individual has abnormal levels of triglycerides or cholesterol. The risk factors are obesity, hypertension poor lifestyle habits and diabetes. Moreover, the demand for biologics is driven by the dramatic shift in production technology and an expansion of targeted diseases.
The report details the trend, potential and market size of Cholesterol Lowering Biologic Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cholesterol Lowering Biologic Drugsmarket, defines the market attractiveness level of Cholesterol Lowering Biologic Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cholesterol Lowering Biologic Drugs industry, describes the types of Cholesterol Lowering Biologic Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cholesterol Lowering Biologic Drugs market and the development prospects and opportunities of Cholesterol Lowering Biologic Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cholesterol Lowering Biologic Drugs market in Chapter 13.
By Player:
Amgen
Alnylam Pharmaceuticals
Regeneron Pharmaceuticals
By Type:
For Oral Administration
Injectable Drugs
By End-User:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cholesterol Lowering Biologic Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cholesterol Lowering Biologic Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cholesterol Lowering Biologic Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cholesterol Lowering Biologic Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cholesterol Lowering Biologic Drugs Market Analysis and Outlook to 2022
-
7.1 Global Cholesterol Lowering Biologic Drugs Consumption (2017-2022)
-
7.2 United States Cholesterol Lowering Biologic Drugs Consumption (2017-2022)
-
7.3 Europe Cholesterol Lowering Biologic Drugs Consumption (2017-2022)
-
7.4 China Cholesterol Lowering Biologic Drugs Consumption (2017-2022)
-
7.5 Japan Cholesterol Lowering Biologic Drugs Consumption (2017-2022)
-
7.6 India Cholesterol Lowering Biologic Drugs Consumption (2017-2022)
-
7.7 South Korea Cholesterol Lowering Biologic Drugs Consumption (2017-2022)
8 Region and Country-wise Cholesterol Lowering Biologic Drugs Market Analysis and Outlook to 2028
-
8.1 Global Cholesterol Lowering Biologic Drugs Consumption Forecast (2022-2028)
-
8.2 United States Cholesterol Lowering Biologic Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Cholesterol Lowering Biologic Drugs Consumption Forecast (2022-2028)
-
8.4 China Cholesterol Lowering Biologic Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Cholesterol Lowering Biologic Drugs Consumption Forecast (2022-2028)
-
8.6 India Cholesterol Lowering Biologic Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Cholesterol Lowering Biologic Drugs Consumption Forecast (2022-2028)
9 Global Cholesterol Lowering Biologic Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Cholesterol Lowering Biologic Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global For Oral Administration Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injectable Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Cholesterol Lowering Biologic Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drug Stores Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Online Sales Consumption and Growth Rate (2017-2022)
10 Global Cholesterol Lowering Biologic Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Cholesterol Lowering Biologic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global For Oral Administration Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cholesterol Lowering Biologic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Online Sales Consumption Forecast and Growth Rate (2022-2028)
11 Global Cholesterol Lowering Biologic Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cholesterol Lowering Biologic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cholesterol Lowering Biologic Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cholesterol Lowering Biologic Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cholesterol Lowering Biologic Drugs Market Competitive Analysis
-
14.1 Amgen
-
14.1.1 Amgen Company Details
-
14.1.2 Amgen Cholesterol Lowering Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen Cholesterol Lowering Biologic Drugs Product and Service
-
14.2 Alnylam Pharmaceuticals
-
14.2.1 Alnylam Pharmaceuticals Company Details
-
14.2.2 Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Product and Service
-
14.3 Regeneron Pharmaceuticals
-
14.3.1 Regeneron Pharmaceuticals Company Details
-
14.3.2 Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cholesterol Lowering Biologic Drugs
-
Figure Cholesterol Lowering Biologic Drugs Picture
-
Table Global Cholesterol Lowering Biologic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cholesterol Lowering Biologic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cholesterol Lowering Biologic Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cholesterol Lowering Biologic Drugs Consumption by Country (2017-2022)
-
Figure United States Cholesterol Lowering Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Cholesterol Lowering Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Cholesterol Lowering Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Cholesterol Lowering Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Cholesterol Lowering Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cholesterol Lowering Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Cholesterol Lowering Biologic Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Cholesterol Lowering Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cholesterol Lowering Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cholesterol Lowering Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cholesterol Lowering Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cholesterol Lowering Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cholesterol Lowering Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global For Oral Administration Consumption and Growth Rate (2017-2022)
-
Figure Global Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Online Sales Consumption and Growth Rate (2017-2022)
-
Figure Global For Oral Administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Sales Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cholesterol Lowering Biologic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cholesterol Lowering Biologic Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Cholesterol Lowering Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Cholesterol Lowering Biologic Drugs Product and Service
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Product and Service
-
Table Regeneron Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Product and Service
-
